357 related articles for article (PubMed ID: 8827076)
1. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
Reeve AE
Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
[TBL] [Abstract][Full Text] [Related]
2. Genomic imprinting and Wilms' tumor.
Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of Beckwith-Wiedemann syndrome.
Weksberg R; Squire JA
Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
[TBL] [Abstract][Full Text] [Related]
5. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
6. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
[TBL] [Abstract][Full Text] [Related]
7. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
8. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
9. Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor.
Riccio A; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Ferrero GB; Silengo MC; Russo S; Larizza L; Cerrato F
Endocr Dev; 2009; 14():1-9. PubMed ID: 19293570
[TBL] [Abstract][Full Text] [Related]
10. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
Weksberg R; Shen DR; Fei YL; Song QL; Squire J
Nat Genet; 1993 Oct; 5(2):143-50. PubMed ID: 8252039
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
[TBL] [Abstract][Full Text] [Related]
12. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Oswald M; Lausch E; Schmidtke P; Reutzel D; Fees S; Lucito R; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4085-90. PubMed ID: 15743916
[TBL] [Abstract][Full Text] [Related]
13. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism.
Ogawa O; Becroft DM; Morison IM; Eccles MR; Skeen JE; Mauger DC; Reeve AE
Nat Genet; 1993 Dec; 5(4):408-12. PubMed ID: 8298652
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders.
Demars J; Shmela ME; Rossignol S; Okabe J; Netchine I; Azzi S; Cabrol S; Le Caignec C; David A; Le Bouc Y; El-Osta A; Gicquel C
Hum Mol Genet; 2010 Mar; 19(5):803-14. PubMed ID: 20007505
[TBL] [Abstract][Full Text] [Related]
15. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.
Sperandeo MP; Ungaro P; Vernucci M; Pedone PV; Cerrato F; Perone L; Casola S; Cubellis MV; Bruni CB; Andria G; Sebastio G; Riccio A
Am J Hum Genet; 2000 Mar; 66(3):841-7. PubMed ID: 10712200
[TBL] [Abstract][Full Text] [Related]
16. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
Wada M; Seeger RC; Mizoguchi H; Koeffler HP
Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
[TBL] [Abstract][Full Text] [Related]
18. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
[TBL] [Abstract][Full Text] [Related]
19. Somatic overgrowth associated with overexpression of insulin-like growth factor II.
Morison IM; Becroft DM; Taniguchi T; Woods CG; Reeve AE
Nat Med; 1996 Mar; 2(3):311-6. PubMed ID: 8612230
[TBL] [Abstract][Full Text] [Related]
20. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.
Cerrato F; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Rinaldi MM; Boccuto L; Neri G; Magnani C; D'Angelo P; Collini P; Perotti D; Sebastio G; Maher ER; Riccio A
Hum Mol Genet; 2008 May; 17(10):1427-35. PubMed ID: 18245780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
